drugset / Trial / NCT00000298

Buprenorphine Combination Tablet Feasibility - 1

NCT00000298

Double-blindTreatment

Summary

The purpose of this study is to determine target dose range of buprenorphine/naloxone combination tablet that provides therapeutic response in opiate addicts with low to moderate dependence, and to identify appropriate initial induction dose in opiate addicts with low to moderate dependence."

Timeline

Start
1995-08
Primary completion
Completion

Publications

  • Background Buprenorphine/nalaxone cmbination tablet: First clinical experience (j. Add Dis 1997, in press). Buprenorphine/naloxone combination tablet: First clincial experience (J Add Dis 1997, in press).

Drugs

EvaluationDrugModalityDoseRoute
Subject Buprenorphine Other / unclassified
Subject Naloxone Small molecule